GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Cash Ratio

Qilian International Holding Group (Qilian International Holding Group) Cash Ratio : 3.37 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Qilian International Holding Group's Cash Ratio for the quarter that ended in Sep. 2023 was 3.37.

Qilian International Holding Group has a Cash Ratio of 3.37. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Qilian International Holding Group's Cash Ratio or its related term are showing as below:

QLI' s Cash Ratio Range Over the Past 10 Years
Min: 0.3   Med: 0.58   Max: 3.37
Current: 3.37

During the past 7 years, Qilian International Holding Group's highest Cash Ratio was 3.37. The lowest was 0.30. And the median was 0.58.

QLI's Cash Ratio is ranked better than
87.16% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.57 vs QLI: 3.37

Qilian International Holding Group Cash Ratio Historical Data

The historical data trend for Qilian International Holding Group's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Cash Ratio Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Ratio
Get a 7-Day Free Trial 0.39 0.64 0.58 1.56 3.37

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.53 1.56 0.97 3.37

Competitive Comparison of Qilian International Holding Group's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Cash Ratio falls into.



Qilian International Holding Group Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Qilian International Holding Group's Cash Ratio for the fiscal year that ended in Sep. 2023 is calculated as:

Cash Ratio (A: Sep. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=22.419/6.66
=3.37

Qilian International Holding Group's Cash Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash Ratio (Q: Sep. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=22.419/6.66
=3.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Qilian International Holding Group Cash Ratio Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines